Cite

MLA Citation

    Manjiao Liu et al.. “Development and validation of a blood-based genomic mutation signature to predict the clinical outcomes of atezolizumab therapy in NSCLC.” Lung cancer, vol. 170, 2022, pp. 148–155. http://access.bl.uk/ark:/81055/vdc_100160177400.0x000040
  
Back to record